Aptus Capital Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Buy
2,210
+192
+10% +$22.2K ﹤0.01% 1001
2026
Q1
$241K Sell
2,018
-1,088
-35% -$143K ﹤0.01% 947
2025
Q4
$423K Buy
3,106
+124
+4% +$17.8K ﹤0.01% 786
2025
Q3
$440K Sell
2,982
-2,044
-41% -$283K ﹤0.01% 734
2025
Q2
$650K Buy
5,026
+2,618
+109% +$317K 0.01% 623
2025
Q1
$288K Sell
2,408
-77
-3% -$9.54K ﹤0.01% 777
2024
Q4
$288K Buy
2,485
+734
+42% +$92.8K ﹤0.01% 779
2024
Q3
$236K Buy
1,751
+50
+3% +$6.69K ﹤0.01% 722
2024
Q2
$231K Buy
+1,701
New +$231K ﹤0.01% 701

Other funds holding XYL

Aptus Capital Advisors's XYL Position: Q2 2026 in Review

Aptus Capital Advisors increased its Xylem (XYL) stake by 9.5% in Q2 2026, buying an estimated $22.2K and bringing the position to 2,210 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #1001.

Aptus Capital Advisors first reported a position in XYL in Q2 2024 and has held it in 9 quarters since. The position peaked at $650K in Q2 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Aptus Capital Advisors held 2,210 shares of Xylem worth $261K as of Q2 2026.
  • Aptus Capital Advisors bought 192 Xylem shares in Q2 2026, an estimated $22.2K.
  • Xylem made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1001 holding.
  • Aptus Capital Advisors first reported a position in Xylem in Q2 2024 and has held it in 9 quarters since.
  • Aptus Capital Advisors's Xylem position peaked at $650K in Q2 2025.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.